Skip to main content
Search
section
Global
News
Careers
Language & Country Selector for Desktop
United States
|
en
Choose Location
Americas
Asia Pacific
Europe
International
Middle East & Africa
Argentina |
es
Brazil |
pt
Canada |
en
Canada |
fr
Central America |
es
Colombia |
es
Latin America |
es
Mexico |
es
United States |
en
Venezuela |
es
Australia |
en
Bangladesh |
en
Hong Kong S.A.R. |
zh
India |
en
Indonesia |
en
Japan |
ja
Korea |
ko
Mainland China |
zh
Malaysia |
en
Pakistan |
en
Philippines |
en
Taiwan |
zh
Austria |
de
Belgium |
fr
Belgium |
nl
Bulgaria |
bg
Czech Republic |
cs
Czech Republic |
en
Denmark |
da
Estonia |
et
Finland |
fi
France |
fr
Germany |
de
Greece |
el
Hungary |
hu
Ireland |
en
Italy |
it
Latvia |
lv
Lithuania |
lt
Netherlands |
nl
Norway |
no
Poland |
pl
Portugal |
pt
Romania |
ro
Russia |
ru
Serbia |
sr
Singapore |
en
Slovakia |
sk
Spain |
es
Sweden |
sv
Switzerland |
de
Switzerland |
fr
United Kingdom |
en
Global |
en
Novartis Foundation |
en
Sandoz |
en
Egypt |
en
South Africa |
en
Turkey |
tr
Language & Country Selector for Mobile
US
Choose Location
americas
Americas
Asia Pacific
Europe
International
Middle East & Africa
Argentina |
es
Australia |
en
Austria |
de
Bangladesh |
en
Belgium |
fr
Belgium |
nl
Brazil |
pt
Bulgaria |
bg
Canada |
en
Canada |
fr
Central America |
es
Colombia |
es
Czech Republic |
cs
Czech Republic |
en
Denmark |
da
Egypt |
en
Estonia |
et
Finland |
fi
France |
fr
Germany |
de
Global |
en
Greece |
el
Hong Kong S.A.R. |
zh
Hungary |
hu
India |
en
Indonesia |
en
Ireland |
en
Italy |
it
Japan |
ja
Korea |
ko
Latin America |
es
Latvia |
lv
Lithuania |
lt
Mainland China |
zh
Malaysia |
en
Mexico |
es
Netherlands |
nl
Norway |
no
Novartis Foundation |
en
Pakistan |
en
Philippines |
en
Poland |
pl
Portugal |
pt
Romania |
ro
Russia |
ru
Sandoz |
en
Serbia |
sr
Singapore |
en
Slovakia |
sk
South Africa |
en
Spain |
es
Sweden |
sv
Switzerland |
de
Switzerland |
fr
Taiwan |
zh
Turkey |
tr
United Kingdom |
en
United States |
en
Venezuela |
es
Menu
About
Novartis in the US
Company at a Glance
By the Numbers
Diversity and Inclusion
Pay Transparency-EPIC
Our Code of Ethics
Strategy
Diversity and Inclusion
Ensuring Equity
The Spirit of Inclusivity
Toward a better society
Parental Leave
Standing for Racial Equity and Justice as One Novartis
Novartis US EEO / D&I Report 2021
Supplier Diversity
People and Culture
Products
Country Leadership Team
External Funding
Contact Us
About
Patients and Caregivers
Novartis Commitment to Patients and Caregivers
Patient Assistance
Diseases
Participating in Clinical Trials
Patient Perspectives
Adverse Event Reporting
The STEP Program
Sickle Cell Disease (SCD)
Program Overview
Multiple Sclerosis (MS)
Cancer
Application for Funding to Help Address Health Disparities
Health Disparities
Patients and Caregivers
Healthcare Professionals
Novartis Pipeline
Novartis Clinical Trials
Adverse Event Reporting
Healthcare Professionals
ESG
Ethical Behavior
Code of Ethics
SpeakUp
PhRMA Code on Interactions with Healthcare Professionals
Business Principles
Ethics, Risk and Compliance
Compliance Program
State Laws
Corporate Integrity Agreement
Payments to HCPs & HCOs
Enhanced Verification Request
Corporate Responsibility
Population Health
Novartis in Society US Reports
Novartis US Foundation
Environmental Sustainability
People and Communities
Beacon of Hope
Beacon of Hope: Measurable solutions for health equity
ESG
News
News Archive
Statements
Stories
Contacts
News
Careers
Career Search
Meet the Teams
Early Career
Personal Growth
How We Work
Employee Benefits
Diversity and Inclusion
Awards & Recognition
Careers
Coronavirus
Coronavirus
Home
Home
News
News Archive
- Any -
In The News
Media Release
Featured News
Story
News Type Filters
Language
- Any -
English
News Archive Navigation
News Archive Navigation
All
Media Releases
Stories
Statements
icon
List View
Showing 15 results
March 2023
Featured News
Mar 16, 2023
Highlighting the Unmet Needs in Hidradenitis Suppurativa (HS)
Featured News
Mar 09, 2023
Radioligand Therapy Supply Information
November 2021
Featured News
Nov 30, 2021
Updated packaging now available for SANDIMMUNE® 100 mg blister packages
July 2021
Featured News
Jul 20, 2021
Beacon of Hope: Addressing health disparities through holistic community-based collective action
January 2021
Featured News
Jan 05, 2021
Novartis US response to COVID-19
October 2020
Featured News
Oct 30, 2020
New policy related to the 340B program
September 2020
Featured News
Sep 30, 2020
Life Science Companies and the Bill & Melinda Gates Foundation: Joint Communique
July 2020
Featured News
Jul 27, 2020
Notice to Healthcare Providers and Entities
June 2020
Featured News
Jun 15, 2020
Standing for Racial Equity and Justice as One Novartis
April 2020
Featured News
Apr 17, 2020
Novartis joins the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative
March 2020
Featured News
Mar 11, 2020
Novartis provides update on use and safety of Beovu® in patients with wet AMD
February 2020
Featured News
Feb 18, 2020
Corrective Action for Certain 100-mg SANDIMMUNE® and NEORAL® Blister Packages in the US
Pagination
1
2
›
Next page